Friday, December 7, 2007
Lilly's Diplomatic Reponse
"Dear Dr. Carlat - We are sorry that you misunderstood the purpose and the message of the risk management program that Lilly supported.
The underlying message of this program is that the best way for psychiatrists – and all physicians – to manage their risk of litigation, happens to be to do what’s also best for their patients – provide good clinical care, be informed, communicate and document the care.
With the barrage of plaintiffs’ lawyer advertising – against Lilly medicines and numerous products made by other pharmaceutical companies – we know that there is misunderstanding and anxiety in the psychiatric community about the risk of litigation and malpractice. For example, Lilly and the National Council for Community Behavioral Healthcare announced in June, 2007, the results of a survey of 400 psychiatrists that showed that more than half had patients who stopped taking antipsychotic medication or reduced their dosages based upon fears raised by law firm advertising. We believe that any information that can help a physician reduce this anxiety and uncertainty will also help return his or her focus to good patient care, which is what is most important.
This program is an attempt to provide helpful, independent, non-product-specific information to psychiatrists to keep the risk of litigation in perspective and to understand what they can appropriately do to reduce that risk.
Initial feedback from psychiatrists who have participated in the program has been overwhelmingly positive.
Please don't hesitate to contact me if you have additional questions.
Global Product Communications
Eli Lilly and Company"
What's that in the air? Ahhh, the sweet smell of damage control.
at 3:37 PM